Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate...

Journal of Clinical Oncology 2011 / 07 Vol. 29; Iss. 21

Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification

Guo, J., Si, L., Kong, Y., Flaherty, K. T., Xu, X., Zhu, Y., Corless, C. L., Li, L., Li, H., Sheng, X., Cui, C., Chi, Z., Li, S., Han, M., Mao, L., Lin, X., Du, N., Zhang, X., Li, J., Wang, B., Qin, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2010.33.9275
Date:
July, 2011
File:
PDF, 1.07 MB
english, 2011
Conversion to is in progress
Conversion to is failed